Literature DB >> 9077519

Antiinflammatory potential of lipoxygenase-derived eicosanoids: a molecular switch at 5 and 15 positions?

C N Serhan, J M Drazen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9077519      PMCID: PMC507925          DOI: 10.1172/JCI119268

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

Review 1.  Lipoxin biosynthesis and its impact in inflammatory and vascular events.

Authors:  C N Serhan
Journal:  Biochim Biophys Acta       Date:  1994-04-14

Review 2.  Lipid mediator networks in cell signaling: update and impact of cytokines.

Authors:  C N Serhan; J Z Haeggström; C C Leslie
Journal:  FASEB J       Date:  1996-08       Impact factor: 5.191

3.  Altered responses of human macrophages to lipopolysaccharide by hydroperoxy eicosatetraenoic acid, hydroxy eicosatetraenoic acid, and arachidonic acid. Inhibition of tumor necrosis factor production.

Authors:  J V Ferrante; Z H Huang; M Nandoskar; C S Hii; B S Robinson; D A Rathjen; A Poulos; C P Morris; A Ferrante
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

4.  Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes.

Authors:  G M Nassar; J D Morrow; L J Roberts; F G Lakkis; K F Badr
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

5.  Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid.

Authors:  J Y Vanderhoek; R W Bryant; J M Bailey
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

6.  Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.

Authors:  C N Serhan; J F Maddox; N A Petasis; I Akritopoulou-Zanze; A Papayianni; H R Brady; S P Colgan; J L Madara
Journal:  Biochemistry       Date:  1995-11-07       Impact factor: 3.162

7.  Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3.

Authors:  M Brungs; O Rådmark; B Samuelsson; D Steinhilber
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

8.  Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions.

Authors:  T Hiltunen; J Luoma; T Nikkari; S Ylä-Herttuala
Journal:  Circulation       Date:  1995-12-01       Impact factor: 29.690

9.  Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.

Authors:  J Clària; C N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

  9 in total
  5 in total

Review 1.  Paradigm shift in the pharmacological management of periodontal diseases.

Authors:  Hatice Hasturk; Alpdogan Kantarci; Thomas E Van Dyke
Journal:  Front Oral Biol       Date:  2011-11-11

2.  Immune responses in tuberculosis: antibodies and CD4-CD8 lymphocytes with vascular adhesion molecules and cytokines (chemokines) cause a rapid antigen-specific cell infiltration at sites of bacillus Calmette-Guérin reinfection.

Authors:  T Shigenaga; A M Dannenberg; D B Lowrie; W Said; M J Urist; H Abbey; B H Schofield; P Mounts; K Sugisaki
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

Review 3.  The biological activity of auranofin: implications for novel treatment of diseases.

Authors:  J M Madeira; D L Gibson; W F Kean; A Klegeris
Journal:  Inflammopharmacology       Date:  2012-09-11       Impact factor: 4.473

4.  Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes.

Authors:  Marcelo O Freire; Jesmond Dalli; Charles N Serhan; Thomas E Van Dyke
Journal:  J Immunol       Date:  2016-12-19       Impact factor: 5.422

Review 5.  Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases.

Authors:  Thomas Sonnweber; Alex Pizzini; Manfred Nairz; Günter Weiss; Ivan Tancevski
Journal:  Int J Mol Sci       Date:  2018-10-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.